Bank of America’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-164,000
| Closed | -$31.4M | – | 7500 |
|
|
2019
Q4 | $31.4M | Buy |
164,000
+4,000
| +3% | +$722K | ﹤0.01% | 1511 |
|
|
2019
Q3 | $26.9M | Buy |
160,000
+143,700
| +882% | +$23.4M | ﹤0.01% | 1579 |
|
|
2019
Q2 | $2.73M | Sell |
16,300
-21,900
| -57% | -$3.03M | ﹤0.01% | 3776 |
|
|
2019
Q1 | $5.59M | Sell |
38,200
-85,900
| -69% | -$12.5M | ﹤0.01% | 3054 |
|
|
2018
Q4 | $16.6M | Sell |
124,100
-130,000
| -51% | -$21.3M | ﹤0.01% | 1827 |
|
|
2018
Q3 | $48.4M | Buy |
254,100
+14,200
| +6% | +$2.61M | 0.01% | 1126 |
|
|
2018
Q2 | $40M | Buy |
239,900
+197,700
| +468% | +$31.7M | 0.01% | 1252 |
|
|
2018
Q1 | $7.1M | Sell |
42,200
-347,800
| -89% | -$58.3M | ﹤0.01% | 2739 |
|
|
2017
Q4 | $63.8M | Buy |
390,000
+160,400
| +70% | +$28.8M | 0.01% | 955 |
|
|
2017
Q3 | $47.1M | Buy |
229,600
+97,600
| +74% | +$22.7M | 0.01% | 1187 |
|
|
2017
Q2 | $32.1M | Sell |
132,000
-261,700
| -66% | -$61.5M | 0.01% | 1339 |
|
|
2017
Q1 | $94.1M | Sell |
393,700
-249,500
| -39% | -$58.1M | 0.02% | 707 |
|
|
2016
Q4 | $135M | Buy |
643,200
+467,500
| +266% | +$96.8M | 0.03% | 545 |
|
|
2016
Q3 | $40.5M | Buy |
175,700
+8,900
| +5% | +$2.17M | 0.01% | 1119 |
|
|
2016
Q2 | $38.5M | Buy |
166,800
+10,300
| +7% | +$2.37M | 0.01% | 1147 |
|
|
2016
Q1 | $41.9M | Sell |
156,500
-3,261,000
| -95% | -$933M | 0.01% | 1050 |
|
|
2015
Q4 | $1.07B | Buy |
3,417,500
+3,319,400
| +3,384% | +$988M | 0.25% | 100 |
|
|
2015
Q3 | $26.7M | Sell |
98,100
-155,700
| -61% | -$47.8M | 0.01% | 1393 |
|
|
2015
Q2 | $77M | Buy |
253,800
+8,200
| +3% | +$2.45M | 0.03% | 669 |
|
|
2015
Q1 | $73.1M | Buy |
245,600
+209,300
| +577% | +$59.7M | 0.02% | 642 |
|
|
2014
Q4 | $9.34M | Sell |
36,300
-85,900
| -70% | -$21.5M | ﹤0.01% | 1994 |
|
|
2014
Q3 | $29.5M | Buy |
122,200
+54,900
| +82% | +$12.3M | 0.01% | 1143 |
|
|
2014
Q2 | $15M | Buy |
67,300
+31,400
| +87% | +$6.5M | ﹤0.01% | 1610 |
|
|
2014
Q1 | $7.39M | Buy |
35,900
+30,700
| +590% | +$6.08M | ﹤0.01% | 2033 |
|
|
2013
Q4 | $874K | Sell |
5,200
-1,700
| -25% | -$266K | ﹤0.01% | 4202 |
|
|
2013
Q3 | $994K | Sell |
6,900
-47,500
| -87% | -$6.33M | ﹤0.01% | 3962 |
|
|
2013
Q2 | $6.87M | Buy |
+54,400
| New | +$6.16M | ﹤0.01% | 2019 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Bank of America's AGN Position: Q2 2020 in Review
Bank of America sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 8,432,014 shares — an estimated $1.49B sold.
Bank of America first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.49B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Bank of America reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Bank of America sold 8,432,014 Allergan plc shares in Q2 2020, an estimated $1.49B.
- Bank of America first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Bank of America's Allergan plc position peaked at $1.49B in Q1 2020.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Bank of America's 13F filing for Q2 2020, filed 14 Aug 2020.